A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker

Annals of the Rheumatic Diseases

Volumn 74, Issue 9, 2015, Pages 1645-1650

  Fisher, Benjamin A ^a,b   Brown, Rachel M ^b   Bowman, Simon J ^b   Barone, Francesca ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTIDINE DEAMINASE; RHEUMATOID FACTOR;

ARTICLE; B LYMPHOCYTE; HISTOPATHOLOGY; HUMAN; KERATOCONJUNCTIVITIS SICCA; LIP BIOPSY; LYMPHOCYTIC SIALADENITIS; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SCORING SYSTEM; SIALOADENITIS; SJOEGREN SYNDROME; T LYMPHOCYTE; BIOPSY; CLINICAL TRIAL (TOPIC); PATHOLOGY; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

BIOPSY; CLINICAL TRIALS AS TOPIC; HUMANS; PROGNOSIS; SALIVARY GLANDS; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 84942094890     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207499     Document Type: Article

References (67)

1. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
2. Caporali R, Bonacci E, Epis O, et al. Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum 2008;59:714-20.
3. Pijpe J, Kalk WW, van der Wal JE, et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2007;46:335-41.
4. Greenspan JS, Daniels TE, Talal N, et al. The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974;37:217-29.
5. Daniels TE. Labial salivary gland biopsy in Sjogren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147-56.
6. Daniels TE, Cox D, Shiboski CH, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren's syndrome among 1,726 registry participants. Arthritis Rheum 2011;63:2021-30.
7. Radfar L, Kleiner DE, Fox PC, et al. Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 2002;47:520-4.
8. http://sicca.ucsf.edu/Labial-Salivary-Gland-Assessment.doc
9. Scott J. Qualitative and quantitative observations on the histology of human labial salivary glands obtained post mortem. J Biol Buccale 1980;8:187-200.
10. Bookman AA, Shen H, Cook RJ, et al. Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjogren's syndrome but not patients with sicca. Arthritis Rheum 2011;63:2014-20.
11. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol 1968;21:656-60.
12. Morbini P, Manzo A, Caporali R, et al. Multilevel examination of minor salivary gland biopsy for Sjogren's syndrome significantly improves diagnostic performance of AECG classification criteria. Arthritis Res Ther 2005;7:R343-8.
13. Vivino FB, Gala I, Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002;29:938-44.
14. Risselada AP, Looije MF, Kruize AA, et al. The role of ectopic germinal centers in the immunopathology of primary Sjogren's syndrome: a systematic review. Semin Arthritis Rheum 2013;42:368-76.
15. Pitzalis C, Jones GW, Bombardieri M, et al. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 2014;14:447-62.
16. Barone F, Bombardieri M, Manzo A, et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 2005;52:1773-84.
17. Bombardieri M, Barone F, Humby F, et al. Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome. J Immunol 2007;179:4929-38.
18. Salomonsson S, Jonsson MV, Skarstein K, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum 2003;48:3187-201.
19. Fox RI. The importance of minor salivary gland biopsy in prediction of lymphoma in Sjogren's syndrome: should we be obtaining more information about prognosis from minor salivary gland samples? Ann Rheum Dis 2011;70:1351-3.
20. Voulgarelis M, Dafni UG, Isenberg DA, et al. Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome. Arthritis Rheum 1999;42:1765-72.
21. Theander E, Vasaitis L, Baecklund E, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome. Ann Rheum Dis 2011;70:1363-8.
22. Risselada AP, Kruize AA, Goldschmeding R, et al. The prognostic value of routinely performed minor salivary gland assessments in primary Sjogren's syndrome. Ann Rheum Dis 2014;73:1537-40.
23. Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103-9.
24. Seror R, Ravaud P, Mariette X, et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011;70:968-72.
25. Ng WF, Bowman SJ. Primary Sjogren's syndrome: too dry and too tired. Rheumatology (Oxford) 2010;49:844-53.
26. Boers M, Brooks P, Strand CV, et al. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
27. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjogren's syndrome. Arthritis Rheum 1994;37:869-77.
28. Dinerman H, Goldenberg DL, Felson DT. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol 1986;13:368-73.
29. Rhodus NL, Fricton J, Carlson P, et al. Oral symptoms associated with fibromyalgia syndrome. J Rheumatol 2003;30:1841-5.
30. Haldorsen K, Moen K, Jacobsen H, et al. Exocrine function in primary Sjogren syndrome: natural course and prognostic factors. Ann Rheum Dis 2008;67:949-54.
31. Atkinson JC, Travis WD, Slocum L, et al. Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjogren's syndrome. Arthritis Rheum 1992;35:1368-72.
32. Jonsson R, Kroneld U, Backman K, et al. Progression of sialadenitis in Sjogren's syndrome. Br J Rheumatol 1993;32:578-81.
33. Miletich I. Introduction to salivary glands: structure, function and embryonic development. Front Oral Biol 2010;14:1-20.
34. Pennec YL, Leroy JP, Jouquan J, et al. Comparison of labial and sublingual salivary gland biopsies in the diagnosis of Sjogren's syndrome. Ann Rheum Dis 1990;49:37-9.
35. Carbone A, Gloghini A, Ferlito A. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type. Ann Otol Rhinol Laryngol 2000;109(12 Pt 1):1170-5.
36. Guellec D, Cornec D, Jousse-Joulin S, et al. Diagnostic value of labial minor salivary gland biopsy for Sjogren's syndrome: a systematic review. Autoimmun Rev 2013;12:416-20.
37. van Bijsterveld OP, Kruize AA, Bleys RL. Central nervous system mechanisms in Sjogren's syndrome. Br J Ophthalmol 2003;87:128-30.
38. Dawson L, Tobin A, Smith P, et al. Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going? Arthritis Rheum 2005;52:2984-95.
39. Talal N, Asofsky R, Lightbody P. Immunoglobulin synthesis by salivary gland lymphoid cells in Sjogren's syndrome. J Clin Invest 1970;49:49-54.
40. Tarpley TM Jr, Anderson LG, White CL. Minor salivary gland involvement in Sjogren's syndrome. Oral Surg Oral Med Oral Pathol 1974;37:64-74.
41. Anderson LG, Cummings NA, Asofsky R, Jr, et al. Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjogren's syndrome. Natural history and response to treatment. Am J Med 1972;53:456-63.
42. Gescuk B, Wu AJ, Whitcher JP, et al. Lamivudine is not effective in primary Sjogren's syndrome. Ann Rheum Dis 2005;64:1326-30.
43. Fox PC, Datiles M, Atkinson JC, et al. Prednisone and piroxicam for treatment of primary Sjogren's syndrome. Clin Exp Rheumatol 1993;11:149-56.
44. Al-Hashimi I, Wright JM, Cooley CA, et al. Reproducibility of biopsy grade in Sjogren's syndrome. J Oral Pathol Med 2001;30:408-12.
45. Kapsogeorgou EK, Christodoulou MI, Panagiotakos DB, et al. Minor salivary gland inflammatory lesions in Sjogren syndrome: do they evolve? J Rheumatol 2013;40:1566-71.
46. Scardina GA, Spano G, Carini F, et al. Diagnostic evaluation of serial sections of labial salivary gland biopsies in Sjogren's syndrome. Med Oral Patol Oral Cir Bucal 2007;12:E565-8.
47. Carubbi F, Cipriani P, Marrelli A, et al. Efficacy and safety of rituximab treatment in early primary Sjogren's syndrome: a prospective, multi-center, follow-up study. Arthritis Res Ther 2013;15:R172.
48. Adler S, Korner M, Forger F, et al. Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjogren's syndrome: a pilot study. Arthritis Care Res (Hoboken) 2013;65:1862-8.
49. Nakayamada S, Fujimoto T, Nonomura A, et al. Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy. Rheumatology (Oxford) 2009;48:1279-82.
50. Tavoni AG, Baldini C, Bencivelli W, et al. Minor salivary gland biopsy and Sjogren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. Clin Exp Rheumatol 2012;30:929-33.
51. Stewart CM, Bhattacharyya I, Berg K, et al. Labial salivary gland biopsies in Sjogren's syndrome: still the gold standard? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:392-402.
52. Costa S, Quintin-Roue I, Lesourd A, et al. Reliability of histopathological salivary gland biopsy assessment in Sjogren's syndrome: a multicentre cohort study. Rheumatology 2015;54:1056-64.
53. Hamza N, Bootsma H, Yuvaraj S, et al. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjogren's syndrome after B cell depletion therapy. Ann Rheum Dis 2012;71:1881-7.
54. Cornec D, Jousse-Joulin S, Pers JO, et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjogren's syndrome: toward new diagnostic criteria? Arthritis Rheum 2013;65:216-25.
55. Szodoray P, Alex P, Jonsson MV, et al. Distinct profiles of Sjogren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 2005;117:168-76.
56. Reksten TR, Jonsson MV, Szyszko EA, et al. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome. Rheumatology (Oxford) 2009;48:1102-6.
57. Delaleu N, Mydel P, Kwee I, et al. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjogren's syndrome. Arthritis Rheumatol 2015;67:1084-95.
58. Yao Y, Liu Z, Jallal B, et al. Type I interferons in Sjogren's syndrome. Autoimmun Rev 2013;12:558-66.
59. Maria NI, Brkic Z, Waris M, et al. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome. Ann Rheum Dis 2014;73:1052-9.
60. Gerli R, Muscat C, Giansanti M, et al. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjogren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol 1997;36:969-75.
61. Bodeutsch C, de Wilde PC, Kater L, et al. Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjogren's syndrome. Arthritis Rheum 1992;35:1075-87.
62. Salomonsson S, Rozell BL, Heimburger M, et al. Minor salivary gland immunohistology in the diagnosis of primary Sjogren's syndrome. J Oral Pathol Med 2009;38:282-8.
63. Zandbelt MM, Wentink JR, de Wilde PC, et al. The synergistic value of focus score and IgA% score of sublabial salivary gland biopsy for the accuracy of the diagnosis of Sjogren's syndrome: a 10-year comparison. Rheumatology (Oxford) 2002;41:819-23.
64. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome. J Autoimmun 2010;34:400-7.
65. Leroy JP, Pennec YL, Soulier C, et al. Follow up study of labial salivary gland lesions in primary Sjogren's syndrome. Ann Rheum Dis 1992; 51:777-80.
66. Skopouli FN, Drosos AA, Papaioannou T, et al. Preliminary diagnostic criteria for Sjogren's syndrome. Scand J Rheumatol Suppl 1986;61:22-5.
67. Mariette X, Ravaud P, Steinfeld S, et al. Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS). Arthritis Rheum 2004;50:1270-6.